Flash News
Resident Evil director Zach Cregger explains why the iPhone is vital to his work New research fills critical gaps in Central America’s freshwater biodiversity knowledge AI’s Next Trick? Speaking Dolphin Best Wireless Chargers (2026): My Picks After Testing 100+ Agility is the first pure humanoid robot company on the stock market. Are you buying? Pioneering Jewish academy opens in Germany A strategist draws a 1980s parallel to argue bipartisanship could power a ‘bull stampede’ Everyone’s Talking About the ‘Blue Tsunami.’ In Japan, It’s Complicated. He Trolls AI Labs for a Living. Now They All Want to Work With Him Why more investment is not making housing affordable in Ghana

Trendmast

Technology news, aggregated

ad slot · header banner 728×90
Science

Will this sleep-disorder drug be the next big blockbuster?

October 20, 2026 · 12:00 am 2 sources

Image: Nature

ad slot · in-content video 16:9

Coverage

Wires & papers of record

  • Will this sleep-disorder drug be the next big blockbuster?
    Nature · October 20, 2026 00:00
    Nature, Published online: 20 October 2026; doi:10.1038/d41586-026-03310-w Orexin agonists have been approved for the treatment of a type of narcolepsy, yet they could also treat conditions across the health spectrum.
  • Daily Briefing: Tiny doses of LSD seem to boost cognition
    Nature · October 20, 2026 00:00
    Nature, Published online: 20 October 2026; doi:10.1038/d41586-026-03374-8 The drug improved the ability to focus — but only in women. Plus, US climate scientists are facing a deluge of public-records requests and why a sleep-disorder drug might be the next big blockbuster.

World

Markets & Economy

Science

Technology

Cyber Security

Gadgets